e-learning
resources
Munich 2006
Wednesday 06.09.2006
In vivo
and
in vitro
aspects of lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression
Y. Nishii, E. C. Gabazza, T. Takagi, T. Maruyama, H. Nakahara, H. Fujimoto, J. Maruyama, T. Kobayashi, H. Kobayashi, C. N. D‘Alessandro-Gabazza, O. Taguchi (Tsu, Japan)
Source:
Annual Congress 2006 -
In vivo
and
in vitro
aspects of lung injury
Session:
In vivo
and
in vitro
aspects of lung injury
Session type:
Poster Discussion
Number:
4748
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Nishii, E. C. Gabazza, T. Takagi, T. Maruyama, H. Nakahara, H. Fujimoto, J. Maruyama, T. Kobayashi, H. Kobayashi, C. N. D‘Alessandro-Gabazza, O. Taguchi (Tsu, Japan). Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression. Eur Respir J 2006; 28: Suppl. 50, 4748
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Tracheobronchomalacia and dynamic airway collapse. Post pneumonectomys
Tracheobronchomalacia and dynamic airway collapse
Post intubation tracheal stenosis
Related content which might interest you:
Enhanced lung fibrosis in protein C inhibitor transgenic mice
Source: Eur Respir J 2004; 24: Suppl. 48, 481s
Year: 2004
Effect of anti-IL17 and/or Rho-kinase inhibitor treatments on vascular remodelling in an asthma model in mice
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
The effect of GM-CSF on lung maturation and parenchymal NOS expression in prenatally treated Balb/c mice
Source: Eur Respir J 2005; 26: Suppl. 49, 341s
Year: 2005
TGF-beta-dependent inhibitor of DNA protein (Id) expression in lung fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 521s
Year: 2006
The effects of chronic hypoxia on pulmonary vascular reactivity in mice genetically deficient in connexin 43
Source: International Congress 2017 – Experimental PH
Year: 2017
Alveolar type 2 cell dysfunction from expression of a surfactant protein C (SFTPC) mutation drives a fibrotic lung phenotype in mice
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
Effect of proteinase inhibitor from
crataeva tapia
(cratabl) in distal lung mechanical, inflammatory and remodeling alterations induced by elastase in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
The effect of bleomycin on the lungs of TGFβ1 transgenic mice
Source: Eur Respir J 2001; 18: Suppl. 33, 80s
Year: 2001
Aminoguanidine attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of heat shock protein 47 and TGF-β1 expression
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
Heat shock protein 90 inhibitors block pulmonary fibrosis and dysfunction in HCl-exposed mice.
Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis
Year: 2017
Effect of eNOS gene overexpression on the vascular reactivity of isolated pulmonary arteries of chronic hypoxic rats
Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease"
Year: 2006
Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling.
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
Tenascin C knockout mice have an altered lung function at newborn and adult age
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017
Effect of NF-?B inhibitor IMD-1041 on BLM-induced pulmonary fibrosis in mice
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Resveratrol attenuates hypoxic pulmonary vascular remodeling in simulated high altitude-exposed rats: potential role of Hif-1α/NOX4/ROS inhibition
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Erythropoietin (EPO) attenuates the immunohistochemical expression of autophagy antibodies in bleomycin (BLM), induced pulmonary fibrosis (PF) in rats
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Premature aging in Zmpste24 deficient mice protects them from bleomycin induced lung fibrosis through upregulation of antifibrotic microRNAs
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept